Journal of Clinical Review & Case Reports(JCRC)

CoFounder, ChemThera Sciences, Canada

Publications

• Case Report   
  Tucaresol: A Unique Oral Candidate Drug Ideally Accessible For Treatment of Covid-19 Disease.
  Author(s): Christopher L Penney*, Boulos Zacharie and Jean-Simon Duceppe
  
  The SARS-CoV-2 pandemic has significantly impacted world health and economic status. In response, much work has been undertaken to provide effective, safe vaccines, antibodies and antiviral drugs with which to address this pandemic. Treatment of a pandemic population presents multiple challenges in addition to the primary issue of drug efficacy and safety, such as large scale drug manufacture and distribution, drug stability, oral dosing and pharmacoeconomic considerations. Ideally, these factors must be addressed if new candidate drugs are to be advanced for treatment of large (pandemic) populations. Subsequently, new antivirals have reached the market but choices are few. According to the NIH Covid Treatment Guidelines, only three small molecule antiviral drugs are available to treat COVID-19 disease. As such, a significant part of the research towards discovery of new antiviral dru.. Read More»
  

  Abstract HTML PDF